Statement of Cash Flows (Tables)

9 Months Ended

Sep. 30, 2025

Cash and Cash Equivalents [Abstract]

Schedule of Cash and Cash Equivalents

The following provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Condensed Consolidated Balance Sheets to the total of the same such amounts shown in the Condensed Consolidated Statements of Cash Flows:

	September 30,
(In millions)	2025		2024
Cash and cash equivalents	$	2,506.4	$	2,011.8
Restricted cash included in Other current assets	6.7		—
Total cash, cash equivalents, and restricted cash shown in the Condensed Consolidated Statements of Cash Flows	$	2,513.1	$	2,011.8

Restrictions on Cash and Cash Equivalents

The following provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Condensed Consolidated Balance Sheets to the total of the same such amounts shown in the Condensed Consolidated Statements of Cash Flows:

	September 30,
(In millions)	2025		2024
Cash and cash equivalents	$	2,506.4	$	2,011.8
Restricted cash included in Other current assets	6.7		—
Total cash, cash equivalents, and restricted cash shown in the Condensed Consolidated Statements of Cash Flows	$	2,513.1	$	2,011.8

Summary of Non-Cash Investing and Financing Activities

	September 30,		December 31,		September 30,		December 31,
(In millions)	2025		2024		2024		2023
Accrued capital expenditures	$	176.9	$	151.6	$	94.0	$	75.4
Accrued contingent consideration in connection with acquisitions	$	52.5	$	62.7	$	88.0	$	71.6